Sanofi India Receives Central Government Approval for Managing Director Appointment
Sanofi India Ltd. announced on April 2, 2026, that it has received Central Government approval for the appointment of Deepak Arora as Director and Managing Director. The approval was granted for a period of three years, effective October 27, 2025, to October 26, 2028.Mr. Arora’s appointment, which was initially disclosed on October 27, 2025, and December 18, 2025, was subject to Central Government approval. The approval letter was received via email on April 1, 2026. Mr. Arora’s Director Identification Number (DIN) is 07495638.
As a condition of the appointment, Mr. Arora is required to provide an undertaking to the company confirming that he will not become involved in any selling agency of Sanofi India without prior approval from the Central Government. The appointment is also contingent upon Mr. Arora regularly residing at a location suitable for attending to his duties.
The Central Government’s approval was conveyed in a letter dated April 1, 2026, and is based on the application filed by Sanofi India on January 21, 2026. The approval is subject to ongoing compliance with the Companies Act, 2013, and any subsequent amendments.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Last edited by a moderator: